{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:06:23Z","timestamp":1791378383105,"version":"4.3.2"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.critrevonc.2022.103825","type":"journal-article","created":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T09:36:01Z","timestamp":1665308161000},"page":"103825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting"],"prefix":"10.1016","volume":"180","author":[{"given":"JC.","family":"Faivre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Demoor-Goldschmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Beddok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Malgras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jovenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Clav\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Scott\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RJ.","family":"Bensadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103825_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exphem.2007.01.010","article-title":"Management of radiation-induced nausea and vomiting","volume":"35","author":"Abdelsayed","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exphem.2007.01.010","article-title":"Management of radiation-induced nausea and vomiting","volume":"35","author":"Abdelsayed","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0090-3019(89)90033-5","article-title":"The acute onset of nausea and vomiting following stereotactic radiosurgery: correlation with total dose to area postrema","volume":"32","author":"Alexander","year":"1989","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bjc.1995.452","article-title":"Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients","volume":"72","author":"Alfieri","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib5","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2018.08.003","article-title":"Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting","volume":"130","author":"Beddok","year":"2019","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/pbc.25088","article-title":"Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma","volume":"61","author":"Casey","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S1470-2045(15)00199-0","article-title":"Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial","volume":"16","author":"Chow","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib9","first-page":"41","article-title":"Effect of brain stem and dorsal vagus complex dosimetry on nausea and vomiting in head and neck intensity-modulated radiation therapy","volume":"36","author":"Ciura","year":"2011","journal-title":"Med. Dosim. Off. J. Am. Assoc. Med. Dosim."},{"key":"10.1016\/j.critrevonc.2022.103825_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13014-015-0547-9","article-title":"Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: a prospective analysis","volume":"10","author":"Cox","year":"2015","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.critrevonc.2022.103825_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0009-9260(79)80203-2","article-title":"The acute radiation syndrome. A memorial to William Michael Court-Brown","volume":"30","author":"Danjoux","year":"1979","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib12","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.ijrobp.2012.02.031","article-title":"International patterns of practice in the management of radiation therapy-induced nausea and vomiting","volume":"84","author":"Dennis","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2022.103825_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1470-2045(15)00582-3","article-title":"Chemotherapy-induced vomiting in children: some progress, more questions","volume":"17","author":"Dupuis","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/pbc.24508","article-title":"Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients","volume":"60","author":"Dupuis","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pbc.23114","article-title":"Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients","volume":"57","author":"Dupuis","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib16","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/pbc.25063","article-title":"Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients","volume":"61","author":"Dupuis","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib17","article-title":"2016 updated MASCC\/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children","author":"Dupuis","year":"2016","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib18","first-page":"329","article-title":"The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting","volume":"20","author":"Emami","year":"2015","journal-title":"J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"key":"10.1016\/j.critrevonc.2022.103825_bib19","first-page":"23","article-title":"One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient","volume":"17","author":"Enblom","year":"2009","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/893013","article-title":"Prophylactic management of radiation-induced nausea and vomiting","volume":"2015","author":"Feyer","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103825_bib21","first-page":"S5","article-title":"Radiotherapy-induced nausea and vomiting (RINV): MASCC\/ESMO guideline for antiemetics in radiotherapy: update 2009","volume":"19","author":"Feyer","year":"2011","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.annonc.a010675","article-title":"A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy","volume":"7","author":"Franz\u00e9n","year":"1996","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. ESMO"},{"key":"10.1016\/j.critrevonc.2022.103825_bib23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1200\/JCO.2012.43.5818","article-title":"Systematic review of acupuncture in cancer care: a synthesis of the evidence","volume":"31","author":"Garcia","year":"2013","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/pbc.21811","article-title":"Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability","volume":"52","author":"Gore","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1188\/09.CJON.54-64","article-title":"Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes","volume":"13","author":"Hawkins","year":"2009","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.critrevonc.2022.103825_bib26","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting","volume":"358","author":"Hesketh","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2022.103825_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1997.15.1.103","article-title":"Proposal for classifying the acute emetogenicity of cancer chemotherapy","volume":"15","author":"Hesketh","year":"1997","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijrobp.2004.07.722","article-title":"Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?","volume":"60","author":"Horiot","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2022.103825_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543776.2010.495121","article-title":"Neurokinin-1 receptor antagonists: a comprehensive patent survey","volume":"20","author":"Huang","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.critrevonc.2022.103825_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijrobp.2015.04.037","article-title":"Addition of the neurokinin-1-receptor antagonist (RA) aprepitant to a 5-hydroxytryptamine-RA and dexamethasone in the prophylaxis of nausea and vomiting due to radiation therapy with concomitant cisplatin","volume":"92","author":"Jahn","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103825_bib31","first-page":"S37","article-title":"Antiemetics in children receiving chemotherapy. MASCC\/ESMO guideline update 2009. Support","volume":"19","author":"Jordan","year":"2011","journal-title":"Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2014.02.019","article-title":"Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy","volume":"111","author":"Kocak-Uzel","year":"2014","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(15)00520-3","article-title":"Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study","volume":"17","author":"Kov\u00e1cs","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bmt.1703579","article-title":"Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation","volume":"30","author":"Kusnierczyk","year":"2002","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.critrevonc.2022.103825_bib35","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ijrobp.2007.05.052","article-title":"Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck","volume":"69","author":"Law","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2022.103825_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijrobp.2011.10.010","article-title":"Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer","volume":"84","author":"Lee","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2022.103825_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2009.11.001","article-title":"A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres","volume":"94","author":"Maranzano","year":"2010","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/frne.1994.1012","article-title":"The area postrema and vomiting","volume":"15","author":"Miller","year":"1994","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2007.12.030","article-title":"Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy","volume":"87","author":"Monroe","year":"2008","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000421-199604000-00023","article-title":"Frequency and clinical implications of delayed nausea and delayed emesis","volume":"19","author":"Morrow","year":"1996","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib41","first-page":"46","article-title":"Progress in reducing anticipatory nausea and vomiting: a study of community practice","volume":"6","author":"Morrow","year":"1998","journal-title":"Support Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/595894","article-title":"Treatment of breakthrough and refractory chemotherapy-induced nausea and vomiting","volume":"2015","author":"Navari","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.critrevonc.2022.103825_bib43","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2022.103825_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"375","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2022.103825_bib45","first-page":"S36","article-title":"Delineation of organs at risk and dose constraints","volume":"20 Suppl","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother. J. Soc. Fr. Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib46","first-page":"CD007786","article-title":"Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood","author":"Phillips","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.critrevonc.2022.103825_bib47","first-page":"1545","article-title":"A novel prospective descriptive analysis of nausea and vomiting among patients receiving gastrointestinal radiation therapy","volume":"24","author":"Poon","year":"2016","journal-title":"Support. Care Cancer . J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0936-6555(05)80086-X","article-title":"A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy","volume":"5","author":"Priestman","year":"1993","journal-title":"Clin. Oncol. R. Coll. Radiol. G. B"},{"key":"10.1016\/j.critrevonc.2022.103825_bib49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0360-3016(99)00055-3","volume":"44","author":"Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103825_bib50","first-page":"S63","article-title":"Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference","volume":"19","author":"Roila","year":"2011","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib51","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103825_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpainsymman.2008.09.006","article-title":"Acupressure bands are effective in reducing radiation therapy-related nausea","volume":"38","author":"Roscoe","year":"2009","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.critrevonc.2022.103825_bib53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2008.01.012","article-title":"Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2022.103825_bib54","article-title":"2016 updated MASCC\/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting","author":"Ruhlmann","year":"2016","journal-title":"Support. Care Cancer . J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib55","first-page":"192","article-title":"Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study","volume":"66","author":"Seynaeve","year":"1992","journal-title":"Ondansetron Study Group. Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103825_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bmt.1702479","article-title":"Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation","volume":"26","author":"Spitzer","year":"2000","journal-title":"Bone Marrow Transpl."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822002499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822002499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:48:22Z","timestamp":1760903302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822002499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":56,"alternative-id":["S1040842822002499"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103825","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103825"}}